Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets-Reference-Cited by-同舟云学术

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets

Published:2008-02 Issue:7182 Volume:451 Page:1076-1081
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Han May H.,Hwang Sun-Il,Roy Dolly B.,Lundgren Deborah H.,Price Jordan V.,Ousman Shalina S.,Fernald Guy Haskin,Gerlitz Bruce,Robinson William H.,Baranzini Sergio E.,Grinnell Brian W.,Raine Cedric S.,Sobel Raymond A.,Han David K.,Steinman Lawrence

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature06559.pdf

Reference38 articles.

1. Lassmann, H., Bruck, W. & Lucchinetti, C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7, 115–121 (2001)

2. Frohman, E. M., Racke, M. K. & Raine, C. S. Multiple sclerosis – the plaque and its pathogenesis. N. Engl. J. Med. 354, 942–955 (2006)

3. Wekerle, H. Immune pathogenesis of multiple sclerosis. Neurol. Sci. 26 (suppl. 1). S1–S2 (2005)

4. Benito, C. et al. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J. Neurosci. 27, 2396–2402 (2007)

5. Kagitani-Shimono, K. et al. Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the αB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol. Appl. Neurobiol. 32, 64–73 (2006)

Cited by 475 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrinolysis associated proteins and lipopolysaccharide bioactivity in plasma and cerebrospinal fluid in multiple sclerosis;Journal of Neuroimmunology;2024-10

2. Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions;Frontiers in Molecular Neuroscience;2024-08-21

3. Circulating platelets modulate oligodendrocyte progenitor cell differentiation during remyelination;eLife;2024-08-20

4. Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid;Biomedicines;2024-07-22

5. Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases;Fluids and Barriers of the CNS;2024-07-19